featured
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American College of Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients
J Am Coll Cardiol 2020 Jun 30;75(25)3140-3147, AC Spyropoulos, W Ageno, GW Albers, CG Elliott, JL Halperin, WR Hiatt, GA Maynard, PG Steg, JI Weitz, W Lu, TE Spiro, ES Barnathan, GE RaskobFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.